Based on the agency, new information regarding cancer risks, and in addition possible defensive benefits against cancer, as regarding oral contraceptives, makes it important that all female who uses hormonal items discuss the dangers and benefits with her doctor. The IARC working band of 21 scientists also have elevated the caution on hormonal menopausal therapy to ‘carcinogenic’ from ‘perhaps carcinogenic’. The researchers concluded, predicated on an expanded research, that ‘mixed menopausal therapy’ improved the chance of breast malignancy and perhaps endometrial cancer.Drachman, President and CEO of AtriCure. We anticipate growth accelerating during the second fifty % of 2012. We believe AtriCure is put to capitalize on our wide variety of premium products, latest AF approval, marketing and education activities, momentum in international marketplaces, and continued expense in regulatory approvals and medical science. First Quarter Financial Results Revenue for the 1st one fourth of 2012 was $17.5 million, a rise of $1.8 million or 11.8 percent in comparison to first quarter 2011 revenue. Domestic income increased 8.8 percent to an archive $13.2 million, including $1.8 million in product sales of the AtriClip program. International revenue was an archive $4.3 million, a rise of $0.8 million or 21.9 percent in comparison with $3.5 million for the first quarter of 2011.